Tanım

Biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. Biomarkers have become vital tools for healthcare and pharmaceutical industries, serving several purposes. The global biomarkers market in terms of revenue is set to grow by US$ 46 sırasında milyar 2021-2027, yıllık bileşik büyüme oranında büyüyor (CAGR) ile ilgili 13.6% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre. Biomarkers are of increasingly high importance in medicine, particularly in the realm of personalized medicine. The factors driving the biomarkers market are increasing demand for personalized medicine, rising government and private funding, increasing prevalence of infectious diseases and various types of cancer globally.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2017-2020 ve tahmin 2027 covering key market aspects like sales value for biomarkers. The global biomarkers market is segmented on the basis of technology, disease, son kullanıcı, ve bölge. Teknolojiye göre, it is categorized into genomics, proteomics, metabolomics, imaging, ve diğerleri. By disease, the biomarkers market is divided into cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, ve diğerleri. Based on end-user, the biomarkers market is divided into hospitals and diagnostics, research and academic institutes, biopharmaceutical and biotech companies, and CROs.

The report has profiled some of the key players of the market such as Abbott Laboratories Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc..

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the biomarkers market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Teknoloji: genomics, proteomics, metabolomics, imaging, ve diğerleri
Disease: cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, ve diğerleri
Son kullanıcı: hospitals and diagnostics, research and academic institutes, biopharmaceutical and biotech companies, and CROs
Bölge: Kuzey Amerika, Asya Pasifik, Avrupa, and Rest of the World (ROW)
Düşünülen Yıllar: bu rapor dönemi kapsamaktadır 2017 ile 2027

Paydaşlar için Temel Faydalar

Get a comprehensive picture of the global biomarkers market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Büyüme sektörlerini ve yatırım eğilimlerini belirleyin
Understand what the future of the global biomarkers market looks like
Rekabet ortamını ve fırsat penceresini belirleyin

İçindekiler

1. Pazar Tanımı
2. Araştırma Metodolojisi
3. Piyasa verileri & Görünüm
3.1 Market değeri
3.2 Piyasa Değeri Tahmini
4. Biomarkers Market by Technology
4.1 Genomics
4.2 Proteomics
4.3 Metabolomics
4.4 Imaging
4.5 Diğerleri
5. Biomarkers Market by Disease
5.1 Cancer
5.2 Cardiovascular And Metabolic Diseases
5.3 Neurodegenerative Diseases
5.4 Infectious Diseases
5.5 Autoimmune Diseases
5.6 Diğerleri
6. Biomarkers Market by End-User
6.1 Hospitals And Diagnostics
6.2 Research And Academic Institutes
6.3 Biopharmaceutical And Biotech Companies
6.4 Cros
7. Biomarkers Market by Region
7.1 Kuzey Amerika
7.2 Asya Pasifik
7.3 Avrupa
7.4 Rest Of The World (Row)
8. Şirket profilleri
8.1 Abbott Laboratories Ltd.
8.2 Becton, Dickinson and Company
8.3 Bio-Rad Laboratories, A.Ş..
8.4 Danaher Corporation
8.5 F. Hoffmann-La Roche Ltd
8.6 PerkinElmer, A.Ş..
8.7 QIAGEN N.V.
8.8 Siemens Healthineers AG
8.9 Thermo Fisher Scientific Inc.
9. Ek
9.1 StratejiHelix Hakkında
9.2 Sorumluluk reddi beyanı